|
|
||||||||
Population Science Division, Fox Chase Cancer Center, Cheltenham, Pa. 19012.
This prospective study was done in a health maintenance organization colorectal cancer screening program to determine whether 166 persons found to have abnormal fecal occult blood test results typically underwent complete diagnostic evaluation (i.e., either colonoscopy or barium enema x-ray plus flexible sigmoidoscopy). Chart audit data show that 137 (82%) subjects contacted a physician to discuss follow-up. A complete diagnostic evaluation was recommended to only 52 (38%) patients who talked with a physician. Forty-two (81%) patients who were advised to get a complete diagnostic evaluation actually complied. Significant differences in clinical findings were observed for patients who did and did not have a complete diagnostic evaluation.
This article has been cited by other articles:
![]() |
M. Sarfaty and R. Wender How to Increase Colorectal Cancer Screening Rates in Practice CA Cancer J Clin, November 1, 2007; 57(6): 354 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Fisher, A. Jeffreys, C. J. Coffman, and K. Fasanella Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1232 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Yabroff, C. N. Klabunde, R. Myers, and M. L. Brown Physician Recommendations for Follow-Up of Positive Fecal Occult Blood Tests Med Care Res Rev, February 1, 2005; 62(1): 79 - 110. [Abstract] [PDF] |
||||
![]() |
M. R. Nadel, J. A. Shapiro, C. N. Klabunde, L. C. Seeff, R. Uhler, R. A. Smith, and D. F. Ransohoff A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood Ann Intern Med, January 18, 2005; 142(2): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Provenzale and R. N. Gray Colorectal Cancer Screening and Treatment: Review of Outcomes Research J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 45 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Yabroff, N. Breen, S. W. Vernon, H. I. Meissner, A. N. Freedman, and R. Ballard-Barbash What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 723 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Yabroff, K. S. Washington, A. Leader, E. Neilson, and J. Mandelblatt Is the Promise of Cancer-Screening Programs Being Compromised? Quality of Follow-Up Care after Abnormal Screening Results Med Care Res Rev, September 1, 2003; 60(3): 294 - 331. [Abstract] [PDF] |
||||
![]() |
S. Glick Double-Contrast Barium Enema for Colorectal Cancer Screening: A Review of the Issues and a Comparison with Other Screening Alternatives Am. J. Roentgenol., June 1, 2000; 174(6): 1529 - 1537. [Full Text] |
||||
![]() |
J. D. Lurie and H. G. Welch Diagnostic Testing Following Fecal Occult Blood Screening in the Elderly J Natl Cancer Inst, October 6, 1999; 91(19): 1641 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Myers, T. Hyslop, M. Gerrity, N. Schlackman, N. Hanchak, J. Grana, B. J. Turner, D. Weinberg, and W. W. Hauck Physician Intention to Recommend Complete Diagnostic Evaluation in Colorectal Cancer Screening Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 587 - 593. [Abstract] [Full Text] |
||||
![]() |
A.-M. Codori, G. M. Petersen, D. L. Miglioretti, E. K. Larkin, M. T. Bushey, C. Young, J. D. Brensinger, K. Johnson, J. A. Bacon, and S. V. Booker Attitudes toward Colon Cancer Gene Testing: Factors Predicting Test Uptake Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |